OR WAIT null SECS
PerkinElmer, Inc., (Waltham, Massachusetts, USA) has announced that it is to establish a personalized health innovation centre of excellence.
PerkinElmer, Inc., (Waltham, Massachusetts, USA) has announced that it is to establish a personalized health innovation centre of excellence. The centre will focus on accelerating scientific innovation to help researchers who are working to eradicate disease and extend the quality and longevity of life.
The centre will bring together leaders from PerkinElmer's chemistry, biochemistry, cell biology, molecular biology and reagent development R&D teams. They will focus on the development of key enabling applications solutions in genomics, imaging, biomarkers, biotherapeutics, targeted small molecule development and cell-based assay solutions. The centre will also showcase a complete solutions-based demonstration laboratory for customers and collaborators.
The centre will be located at the company’s facility in Hopkinton, Massachusetts, USA, and is hoped to be fully operational by late 2012.
Kevin Hrusovsky, President, Life Sciences & Technology, PerkinElmer, said, “We are delighted to establish our new centre of excellence, which will serve as an exciting example of PerkinElmer’s commitment to, and culture of, innovation. The expertise promoted by the centre will help bring novel and disruptive solutions to our customers, aiding their research in next generation treatments, early detection and disease prevention.”